Shigeo Fuji1, Kumi Oshima2, Kazuteru Ohashi3, Masashi Sawa4, Takeshi Saito5, Tetsuya Eto6, Masatsugu Tanaka7, Makoto Onizuka8, Hirohisa Nakamae9, Souichi Shiratori10, Yukiyasu Ozawa11, Michihiro Hidaka12, Tokiko Nagamura13, Hidenori Tanaka14, Takahiro Fukuda15, Tatsuo Ichinohe16, Yoshiko Atsuta17, Masao Ogata18 (1.Osaka International Cancer Institute, Osaka, Japan, 2.Jyoban Hospital, Fukushima, Japan, 3.Komagome Hospital, Tokyo, Japan, 4.Anjo Kosei Hospital, Aichi, Japan, 5.Jikei University School of Medicine, Tokyo, Japan, 6.Hamanomachi Hospital, Fukuoka, Japan, 7.Kanagawa Cancer Center, Kanagawa, Japan, 8.Tokai University School of Medicine, Kanagawa, Japan, 9.Osaka City University Hospital, Osaka, Japan, 10.Hokkaido University Hospital, Hokkaido, Japan, 11.Japanese Red Cross Nagoya First Hospital, Aichi, Japan, 12.National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 13.Institute of Medical Science, University of Tokyo, Tokyo, Japan, 14.HLA laboratory, Kyoto, Japan, 15.National Cancer Center Hospital, Tokyo, Japan, 16.Hiroshima University, Hiroshima, Japan, 17.Japanese Data Center for Hematopoietic Cell Transplantation, 18.Oita University Hospital, Oita, Japan)
Session information
Oral Session
Oral Session 2-14D Post-transplant Complications/Graft Failure/Endothelial Injury
Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.14 (Tokyo International Forum, 6F G610)
Chair: Toshiro Kurokawa (Toyama Red Cross Hospital, Division of Hematology)
Mariko Minami1, Yasuo Mori1, Yasufumi Uehara1, Takuya Nunomura1, Takeshi Sugio1, Goichi Yoshimoto1, Akihiko Numata1, Koji Kato1, Takahiro Maeda2, Toshihiro Miyamoto1, Koichi Akashi1,2 (1.Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 2.Center for Cellular and Molecular Medicine, Kyushu University, Fukuoka, Japan)
Erina Nakahara, Hiroshi Yagasaki, Masaru Ueno, Masataka Ito, Koji Kanezawa, Hirotsugu Okuma, Maiko Hirai, Motoaki Chin, Ichiro Morioka (Pediatrics, Nihon Univ., Tokyo, Japan)
Ken Sagou1, Kazutaka Ozeki1, Yuma Kawamura1, Shun Ukai1, Miyo Goto1,3, Yoshitaka Adachi1,2, Nobuaki Fukushima1, Akio Kohno1 (1.Hematol. and Oncol., Konan Kosei Hospital, Aichi, Japan, 2.Hematol. and Oncol., Nagoya Univ., Aichi, Japan, 3.Hematol., Japanese Red Cross Nagoya Daiichi Hospital, Aichi, Japan)
Akiko Takamatsu, Motoaki Shiratsuchi, Hiroki Muta, Makoto Oyama, Taisuke Narazaki, Mariko Tsuda, Toru Masuda, Daisaku Kimura, Yasuhiro Nakashima, Yoshihiro Ogawa (Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka, Japan)
Masaharu Tamaki, Hideki Nakasone, Shunto Kawamura, Junko Takeshita, Nozomu Yoshino, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Aki Tanihara, Machiko Kusuda, Yu Akahoshi, Koji Kawamura, Shunichi Kimura, Shinichi Kako, Yoshinobu Kanda (Hematol., Saitama Medical Center, Jichi Medical University, Saitama, Japan)